One can improve the value of a product by focusing attention on how you refer to the product you are developing. The first point is to try and find another term than "drug" to describe the product. A few of the many alternative terms are: enzyme replacement, antidote, chemopreparative regimen, essential nutrient. Note that an enzyme replacement does not have to be an enzyme. The connotations of the chosen term may facilitate interactions with regulatory agencies and eventual marketing.

The closer that community based trials can approach the actual practice of medicine, the more willing practicing phsicians will be to accept the results of the trials and apply them to their own patients.

Active drug surveillance techniques can preempt accusations by a vocal consumer activist group that a company is not acting responsibly to investigate and study an issue or problem with one of its drugs.

If more than three people have to approve routine drug development proposals the company has an important issue to investigate as it is not being efficient.